Studies from Stanford University Have Provided New Data on Prostate Cancer (A Pilot Study of 68ga-psma11 and 68ga-rm2 Pet/mri for Evaluation of Prostate Cancer Response To High-intensity Focused Ultrasound Therapy).

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Abstract:
      In this study, we evaluated a novel approach of using both 68Ga-RM2 and 68Ga-PSMA11 PET/MRI in each patient before and after HIFU to assess the accuracy of target tumor localization and response to treatment. Keywords: Stanford; State:California; United States; North and Central America; Cancer; Health and Medicine; High-Intensity Focused Ultrasound Ablation; Oncology; Prostate Cancer; Prostatic Neoplasms; Surgery; Transrectal Ultrasound EN Stanford State:California United States North and Central America Cancer Health and Medicine High-Intensity Focused Ultrasound Ablation Oncology Prostate Cancer Prostatic Neoplasms Surgery Transrectal Ultrasound 1175 1175 1 07/17/23 20230723 NES 230723 2023 JUL 18 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- Fresh data on Oncology - Prostate Cancer are presented in a new report. [Extracted from the article]
    • Abstract:
      Copyright of Medical Devices & Surgical Technology Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)